Micropos Medical: Cooperation for greater awareness of high precision radiotherapy for prostate cancer
GOTHENBURG, Sweden, Nov. 4, 2026 /PRNewswire/ -- Modern radiotherapy for prostate cancer is as effective as surgery with important advantages in preservation of urinary continence and sexual function [1] [2]. Despite growing scientific evidence, radiotherapy remains underutilized in...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 150 stories mentioning NOV, the earliest published 27 Oct 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.